These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 23659106)
1. Multiprofessional and intrahospital experience for diagnosis and treatment of pulmonary arterial hypertension. Correale M; Montrone D; Lacedonia D; Ieva R; Bucci R; Corrado A; Cantatore FP; Greco CA; Concilio M; Serviddio G; Barbaro MP; Di Biase M; Brunetti ND Monaldi Arch Chest Dis; 2012 Dec; 78(4):205-9. PubMed ID: 23659106 [TBL] [Abstract][Full Text] [Related]
2. Screening and treating pulmonary arterial hypertension in a tertiary hospital-based multidisciplinary clinic: the first 200 patients. Low AJ; Fowler D; Manghani MK; Young I; Garsia R; Torzillo P; Youssef P; Celermajer DS Intern Med J; 2013 Jan; 43(1):32-7. PubMed ID: 22032309 [TBL] [Abstract][Full Text] [Related]
3. [Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: diagnostic approach of a single center]. Kayikçioğlu M; Kültürsay H Anadolu Kardiyol Derg; 2008 Aug; 8(4):279-85. PubMed ID: 18676304 [TBL] [Abstract][Full Text] [Related]
4. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis. Modrykamien AM; Gudavalli R; McCarthy K; Parambil J Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729 [TBL] [Abstract][Full Text] [Related]
5. Definitions and diagnosis of pulmonary hypertension. Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D42-50. PubMed ID: 24355641 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study. Derchi G; Galanello R; Bina P; Cappellini MD; Piga A; Lai ME; Quarta A; Casu G; Perrotta S; Pinto V; Musallam KM; Forni GL; Circulation; 2014 Jan; 129(3):338-45. PubMed ID: 24081970 [TBL] [Abstract][Full Text] [Related]
7. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis. Valenzuela A; Nandagopal S; Steen VD; Chung L Rheum Dis Clin North Am; 2015 Aug; 41(3):489-506. PubMed ID: 26210131 [TBL] [Abstract][Full Text] [Related]
8. Current trends in the management of pulmonary hypertension associated with respiratory disease in institutions approved by the Japanese Respiratory Society. Tanabe N; Taniguchi H; Tsujino I; Sakamaki F; Emoto N; Kimura H; Miyaji K; Takamura K; Hayashi S; Hanaoka M; Tatsumi K; Respir Investig; 2014 May; 52(3):167-72. PubMed ID: 24853016 [TBL] [Abstract][Full Text] [Related]
13. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M; Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881 [TBL] [Abstract][Full Text] [Related]
14. Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension. Vicenzi M; Deboeck G; Faoro V; Loison J; Vachiery JL; Naeije R Int J Cardiol; 2016 Jan; 202():736-40. PubMed ID: 26469553 [TBL] [Abstract][Full Text] [Related]
15. Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. Hsu VM; Chung L; Hummers LK; Wigley F; Simms R; Bolster M; Silver R; Fischer A; Hinchcliff ME; Varga J; Goldberg AZ; Derk CT; Schiopu E; Khanna D; Shapiro LS; Domsic RT; Medsger T; Mayes MD; Furst D; Csuka ME; Molitor JA; Alkassab F; Steen VD Semin Arthritis Rheum; 2014 Aug; 44(1):55-62. PubMed ID: 24709277 [TBL] [Abstract][Full Text] [Related]
16. Treatment goals of pulmonary hypertension. McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis. Phung S; Strange G; Chung LP; Leong J; Dalton B; Roddy J; Deague J; Playford D; Musk M; Gabbay E Intern Med J; 2009 Oct; 39(10):682-91. PubMed ID: 19220532 [TBL] [Abstract][Full Text] [Related]
18. [Two years of multidisciplinary diagnostic and therapeutic experience in patients with pulmonary arterial hypertension]. Tokgözoğlu L; Akdoğan A; Okutucu S; Kaya EB; Aytemir K; Ozkutlu H Turk Kardiyol Dern Ars; 2009 Sep; 37(6):378-83. PubMed ID: 20019450 [TBL] [Abstract][Full Text] [Related]
19. Early decline in six-minute walk distance from the time of diagnosis predicts clinical worsening in pulmonary arterial hypertension. Huang J; Mehta S; Mura M Respiration; 2015; 89(5):365-73. PubMed ID: 25791910 [TBL] [Abstract][Full Text] [Related]
20. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population. Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T Appl Health Econ Health Policy; 2011 Sep; 9(5):293-303. PubMed ID: 21875160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]